- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT03748641
Tutkimus niraparibista yhdistelmänä abirateroniasetaatin ja prednisonin kanssa verrattuna abirateroniasetaattiin ja prednisoniin metastasoituneen eturauhassyövän hoitoon (MAGNITUDE)
Kolmannen vaiheen satunnaistettu, lumekontrolloitu kaksoissokkotutkimus niraparibista yhdistelmänä abirateroniasetaatin ja prednisonin kanssa versus abirateroniasetaatti ja prednisoni potilailla, joilla on etäpesäkkeinen eturauhassyöpä
The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP and placebo.
Tutkimuksen yleiskatsaus
Tila
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Vaihe 3
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Amsterdam, Alankomaat, 1066 CX
- Antoni van Leeuwenhoek
-
Groningen, Alankomaat, 9713 GZ
- Universitair Medisch Centrum Groningen
-
Leidschendam, Alankomaat, 2262 BA
- MC Haaglanden Lok Antoniushove - Afd.Interne - INT
-
Nieuwegein, Alankomaat, 3430EM
- St. Antonius Ziekenhuis (St. Antonius Hospital)
-
Nijmegen, Alankomaat, 6532 SZ
- Canisius-Wilhelminaziekenhuis
-
Rotterdam, Alankomaat, 3075 EA
- Erasmus MC
-
Sittard-Geleen, Alankomaat, 6162 BG
- Zuyderland Medical Center
-
-
-
-
-
Buenos Aires, Argentiina, C1118AAT
- Hospital Aleman
-
Buenos Aires, Argentiina, C1426AGE
- Centro Oncológico Korben
-
Buenos Aires, Argentiina, C1431FWN
- CEMIC Saavedra
-
Ciudad Automoma Buenos Aires, Argentiina, C1120AAT
- Centro de Urologia (CDU)
-
Córdoba, Argentiina, X5016KEH
- Hospital Privado Centro Medico de Cordoba
-
Córdoba, Argentiina, 5000
- Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
-
Mar del Plata, Argentiina, B7602CBM
- Hospital Privado de Comunidad
-
Mar del Plata, Argentiina, B7600FZN
- Instituto de Investigaciones Clinicas Mar del Plata
-
Pergamino, Argentiina, B2700CPM
- Centro de Investigacion Pergamino SA
-
Rosario, Argentiina, 2000
- Sanatorio Britanico de Rosario
-
Rosario, Argentiina, S2000SDV
- Sanatorio Parque
-
San Salvador de Jujuy, Argentiina, Y4600AFW
- ARS Médica
-
-
-
-
-
Adelaide, Australia, 5000
- Royal Adelaide Hospital
-
Benowa, Australia, 4217
- Pindara Private Hospital
-
Birtinya, Australia, 4575
- Sunshine Coast University Hospital
-
Brisbane, Australia, 4102
- Princess Alexandra Hospital
-
Darlinghurst, Australia, 2010
- St Vincent s Hospital Sydney
-
Hobart, Australia, 7000
- Royal Hobart Hospital
-
Macquarie University, Australia, 2109
- Macquarie University
-
Malvern, Australia, 3144
- Eye Surgery Associates
-
Melbourne, Australia, 3000
- Peter MacCallum Cancer Centre
-
Murdoch, Australia, 6150
- Fiona Stanley Hospital
-
Nedlands, Australia, 6009
- Hollywood Private Hospital
-
Randwick, Australia, 2031
- Prince Of Wales Hospital
-
Wahroonga, Australia, 2076
- Sydney Adventist Hospital
-
Wollongong, Australia, 2500
- Wollongong Private Hospital
-
-
-
-
-
Aalst, Belgia, 9300
- OLV Ziekenhuis Aalst
-
Antwerp, Belgia, 2610
- ZAS Augustinus
-
Charleroi, Belgia, 6000
- Grand Hopital de Charleroi, site Notre Dame
-
Ghent, Belgia, 9000
- AZ Maria Middelares
-
Liège, Belgia, B-4000
- Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman
-
Merksem, Belgia, 2170
- ZNA Jan Palfijn
-
-
-
-
-
Barretos, Brasilia, 14784-400
- Fundacao Pio XII
-
Belo Horizonte, Brasilia, 30130-090
- PERSONAL Oncologia de Precisao e Personalizada
-
Brasília, Brasilia, 7020-730
- Sociedade Beneficente de Senhoras - Hospital Sirio Libanes HSL Unidade Brasilia
-
Curitiba, Brasilia, 80810 050
- CIONC Centro Integrado de Oncologia de Curitiba
-
Fortaleza, Brasilia, 60 810180
- Pronutrir
-
Goiânia, Brasilia, 74605-070
- Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
-
Ijuí, Brasilia, 98700-000
- Oncosite - Centro de Pesquisa Clínica em Oncologia Ltda
-
Ipatinga, Brasilia, 35162 189
- Fundacao Sao Francisco Xavier
-
Joinville, Brasilia, 89201-260
- Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia
-
Maceió, Brasilia, 57052-765
- Medradius Clinica de Medicina Nuclear e Radiologia de Maceio Ltda.
-
Natal, Brasilia, 59062 000
- Liga Norte Riograndense Contra O Cancer
-
Porto Alegre, Brasilia, 90020-090
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Porto Alegre, Brasilia, 90160-093
- Hospital Ernesto Dornelles
-
Rio de Janeiro, Brasilia, 20551-030
- Universidade do Estado do Rio de Janeiro - UERJ
-
Rio de Janeiro, Brasilia, 22250 905
- Oncoclinicas Rio de Janeiro S A
-
Rio de Janeiro, Brasilia, 22775 001
- Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
-
Rio de Janeiro, Brasilia, 20230 130
- Ministerio da Saude Instituto Nacional do Cancer
-
Salvador, Brasilia, 40050-410
- Hospital Santa Isabel
-
Santo André, Brasilia, 09060-650
- CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia
-
Sorocaba, Brasilia, 18030-005
- IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
-
São Paulo, Brasilia, 04014-002
- Núcleo de Pesquisa São Camilo
-
São Paulo, Brasilia, 01236-030
- Instituto de Ensino e Pesquisa São Lucas
-
São Paulo, Brasilia, 04502-001
- Instituto D Or de Pesquisa e Ensino IDOR
-
São Paulo, Brasilia, 01509 900
- Fundacao Antonio Prudente A C Camargo Cancer Center
-
São Paulo, Brasilia, 04039-004
- Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE
-
São Paulo, Brasilia, 01246 000
- Fundacao Faculdade de Medicina Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, Brasilia, 01221-020
- Irmandade Santa Casa de Misericordia de Sao Paulo
-
São Paulo, Brasilia, 01421-000
- Hospital Alemao Oswaldo Cruz
-
Três Lagoas, Brasilia, 79601-001
- Instituto Do Cancer Brasil
-
-
-
-
-
Burgas, Bulgaria, 8001
- MHAT Deva Maria
-
Pleven, Bulgaria, 5800
- UMHAT 'Dr. Georgi Stranski', EAD
-
Plovdiv, Bulgaria, 4004
- Complex Oncology Center - Plovdiv EOOD
-
Sofia, Bulgaria, 1756
- Specialized Hospital for Active Treatment in Oncology EAD
-
Varna, Bulgaria, 9010
- SHATOD 'Dr. Marko Antonov Markov'
-
Vratsa, Bulgaria, 3001
- Comprehensive Cancer Center
-
-
-
-
-
A Coruña, Espanja, 15006
- Hospital Juan Canalejo
-
Barcelona, Espanja, 08025
- Hosp. de La Santa Creu I Sant Pau
-
Barcelona, Espanja, 08003
- Hosp. Del Mar
-
Barcelona, Espanja, 08036
- Hosp Clinic de Barcelona
-
Jerez de la Frontera, Espanja, 11407
- Hosp. de Jerez de La Frontera
-
Madrid, Espanja, 28040
- Hosp. Clinico San Carlos
-
Madrid, Espanja, 28034
- Hosp. Univ. Ramon Y Cajal
-
Málaga, Espanja, 29010
- Hosp Virgen de La Victoria
-
Pozuelo de Alarcón, Espanja, 28223
- Hosp. Quiron Madrid Pozuelo
-
Sabadell, Espanja, 08208
- Corporacio Sanitari Parc Tauli
-
Santander, Espanja, 39008
- Hosp. Univ. Marques de Valdecilla
-
Valencia, Espanja, 46026
- Hosp. Univ. I Politecni La Fe
-
-
-
-
-
Busan, Etelä -Korea, 49241
- Pusan National University Hospital
-
Daegu, Etelä -Korea, 41404
- Kyungpook National University Chilgok Hospital
-
Daegu, Etelä -Korea, 42601
- Keimyung University Dongsan Hospital
-
Daejeon, Etelä -Korea, 35015
- Chungnam National University Hospital
-
Gwangju, Etelä -Korea, 61469
- Chonnam National University Hospital
-
Gyeonggi-do, Etelä -Korea, 10408
- National Cancer Center
-
Gyeonggi-do, Etelä -Korea, 443-721
- Ajou University Hospital
-
Seongnam-si, Etelä -Korea, 13620
- Seoul National University Bundang Hospital
-
Seoul, Etelä -Korea, 03080
- Seoul National University Hospital
-
Seoul, Etelä -Korea, 05505
- Asan Medical Center
-
Seoul, Etelä -Korea, 03722
- Severance Hospital Yonsei University Health System
-
Seoul, Etelä -Korea, 06351
- Samsung Medical Center
-
Seoul, Etelä -Korea, 06591
- The Catholic University of Korea Seoul St Marys Hospital
-
Seoul, Etelä -Korea, 06273
- Gangnam Severance Hospital, Yonsei University Health System
-
-
-
-
-
Johannesburg, Etelä-Afrikka, 1619
- Clinresco Centres Pty Ltd
-
Pretoria, Etelä-Afrikka, 0001
- Clinical Research Unit
-
-
-
-
-
Beer Yaakov, Israel, 60930
- Asaf Harofe Medical Center
-
Haifa, Israel, 31096
- Rambam Health Care Campus
-
Petah Tikva, Israel, 49100
- Rabin Medical Center
-
Ramat Gan, Israel, 52621
- Sheba Medical Center Tel Hashomer
-
-
-
-
-
Faenza, Italia, 48018
- AUSL Romagna - Ospedale di Faenza
-
Milan, Italia, 20132
- Ospedale San Raffaele
-
Milan, Italia, 20162
- ASST Grande Ospedale Metropolitano Niguarda
-
Naples, Italia, 80131
- Oncologia Medica A - Ist Naz Tumori G Pascale
-
Padova, Italia, 35128
- Istituto Oncologico Veneto Iov Irccs Padova
-
Parma, Italia, 43126
- Oncologia Medica - Azienda Ospedaliero Universitaria Di Parma
-
Perugia, Italia, 06132
- Ospedale S. Maria Della Misericordia Centro Operativo Studi Clinici SC Oncologia Medica
-
Pisa, Italia, 56126
- Azienda Ospedaliero Universitaria Pisana
-
Roma, Italia, 00168
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Roma, Italia, 128
- Campus Bio Medico di Roma
-
Terni, Italia, 5100
- Azienda Ospedaliera S. Maria Terni
-
Torino, Italia, 10126
- A.O.U. Città della Salute e della Scienza
-
Trento, Italia, 38122
- Ospedale Santa Chiara Trento
-
-
-
-
Alberta
-
Calgary, Alberta, Kanada, T2V 1P9
- Southern Alberta Institute of Urology / Prostate Cancer Centre
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 4E6
- British Columbia Cancer Agency BCCA Vancouver Centre
-
Victoria, British Columbia, Kanada, V8R 6V5
- British Columbia Cancer Agency Vancouver Island Centre
-
-
Ontario
-
Hamilton, Ontario, Kanada, L8N 4A6
- McMaster Institute of Urology
-
Kingston, Ontario, Kanada, K7L 3N6
- Cancer Centre of Southeastern Ontario (Kingston Regional Cancer Centre)
-
Toronto, Ontario, Kanada, M5G2M9
- Princess Margaret Cancer Centre University Health Network
-
Toronto, Ontario, Kanada, M4N 3M5
- Sunnybrook Health Sciences Center
-
-
Quebec
-
Montreal, Quebec, Kanada, H2X 0A9
- Centre de Recherche du CHUM
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Kanada, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
-
Beijing, Kiina, 100730
- Beijing Hospital
-
Beijing, Kiina, 100191
- Peking University Third Hospital
-
Beijing, Kiina, 100050
- Beijing Friendship Hospital
-
Beijing, Kiina, 100034
- Peking University First Hospital
-
Beijing, Kiina, 100021
- Cancer Hospital Chinese Academy of Medical Sciences
-
Beijing, Kiina, 100142
- Beijing Cancer Hospital of Peking University
-
Chengdu, Kiina, 610072
- Sichuan Provincial Peoples Hospital
-
Chongqing, Kiina, 400030
- Chongqing University Cancer Hospital
-
Chongqing, Kiina, 400025
- Southwest Hospital, The Third Military Medical University
-
Fuzhou, Kiina, 350001
- Fujian Medical University Union Hospital
-
Guangzhou, Kiina, 510180
- Guangzhou First Municipal People's Hospital
-
Guangzhou, Kiina, 510120
- Sun Yat-Sen Memorial Hospital Sun Yat-sen University
-
Nanjing, Kiina, 210009
- Jiangsu Cancer Hospital
-
Nanjing, Kiina, 210008
- Nanjing Drum Tower Hospital
-
Ningbo, Kiina, 315010
- Drug clinical trial ethics committee of Ningbo First Hospital
-
Shanghai, Kiina, 200032
- Fudan University Shanghai Cancer Center
-
Shanghai, Kiina, 200040
- Huashan Hospital Fudan University
-
Shanghai, Kiina, 200001
- Renji Hospital, Shanghai Jiaotong University School of Medicine
-
Shanghai, Kiina, 200040
- ShangHai Huadong Hospital
-
Shanghai, Kiina, 200240
- The Fifth People's Hospital of Shanghai, Fudan University
-
Suzhou, Kiina, 215006
- The First Affiliated Hospital of Soochow University
-
Tianjin, Kiina, 300060
- Tianjin Medical University Cancer Hospital
-
Wuhan, Kiina, 430014
- The Central Hospital of Wuhan
-
Wuhan, Kiina, 430030
- Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Wuxi, Kiina, 214023
- Wuxi People s Hospital
-
Xi'an, Kiina, 710061
- The First Affiliated Hospital of Xian Jiaotong University
-
-
-
-
-
George Town, Malesia, 10990
- Hospital Pulau Pinang
-
Johor Bahru, Malesia, 81100
- Hospital Sultan Ismail
-
Kota Kinabalu, Malesia, 88996
- Hospital Likas
-
Kuala Lumpur, Malesia, 50586
- Hospital Kuala Lumpur
-
Kuala Lumpur, Malesia, 59100
- University Malaya Medical Centre
-
Kuching, Malesia, 93586
- Sarawak General Hospital
-
-
-
-
-
Aguascalientes, Meksiko, 20010
- iBiomed Research Unit
-
Durango, Meksiko, 34000
- Consultorio de Especialidad en Urologia Privado
-
Mexico City, Meksiko, 03100
- Mexico Centre for Clinical Research, S.A. de C.V.
-
Monterrey, Meksiko, 64710
- Avix Investigacion Clinica S C
-
Zapopan, Meksiko, 45040
- Consultorio Privado
-
-
-
-
-
Coimbra, Portugali, 3000-075
- Instituto Portugues de Oncologia de Coimbra Francisco Gentil, EPE
-
Coimbra, Portugali, 3000-075
- Hospitais da universidade de Coimbra
-
Lisbon, Portugali, 1400-038
- Champalimaud Foundation Champalimaud Centre
-
Lisbon, Portugali, 1649-035
- Centro Hospitalar Lisboa Norte EPE Hosp. Santa Maria
-
Porto, Portugali, 4099-001
- H. Santo António - Centro Hospitalar do Porto
-
-
-
-
-
San Juan, Puerto Rico, 00921
- VA Caribbean Healthcare System
-
-
-
-
-
Bydgoszcz, Puola, 85 094
- Szpital Uniwersytecki NR 1 IM Dr Antoniego Jurasza
-
Bydgoszcz, Puola, 85 796
- Centrum Onkologii im Prof F Lukaszczyka
-
Gdansk, Puola, 80 214
- Uniwersyteckie Centrum Kliniczne
-
Gdynia, Puola, 81 519
- Szpitale Pomorskie Sp z o o
-
Lodz, Puola, 93-509
- Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
-
Siedlce, Puola, 08-110
- Urologica Praktyka Lekarska Adam Marcheluk
-
Szczecin, Puola, 70 111
- Pomorski Uniwersytet Medyczny w Szczecinie
-
Warsaw, Puola, 02-781
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Wroclaw, Puola, 53 413
- Dolnoslaskie Centrum Onkologii
-
-
-
-
-
Besançon, Ranska, 25030
- CHRU De Besancon
-
Bordeaux, Ranska, 33000
- Institut Bergonie
-
Clermont-Ferrand, Ranska, 63011
- Centre Jean Perrin
-
Lyon, Ranska, 69008
- Centre Leon Berard
-
Montpellier, Ranska, 34298
- Institut Regional du Cancer de Montpellier Val d'Aurelle
-
Nancy, Ranska, 54100
- Polyclinique de Gentilly
-
Nice, Ranska, 06189
- Centre Antoine Lacassagne
-
Paris, Ranska, 75908
- Hopital Europeen Georges-Pompidou
-
Saint-Herblain, Ranska, 44805
- Institut de Cancerologie de l Ouest ICO
-
Saint-Mandé, Ranska, 94163
- HIA Begin
-
Strasbourg, Ranska, 67098
- Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre
-
-
-
-
-
Stockholm, Ruotsi, 171 76
- Karolinska Universitetssjukhuset Solna
-
Stockholm, Ruotsi, 11883
- Sodersjukhuset
-
Uppsala, Ruotsi, 751 85
- Akademiska Sjukhuset
-
-
-
-
-
Braunschweig, Saksa, 38126
- Städtisches Klinikum Braunschweig gGmbH - Standort Salzdahlumer
-
Duisburg, Saksa, 47179
- Urologicum Duisburg
-
Homburg, Saksa, 66424
- Universitätsklinikum des Saarlandes
-
Magdeburg, Saksa, 39120
- Universitätsklinikum Otto-von-Guericke-Universität Magdeburg
-
Münster, Saksa, 48149
- Universitaetsklinikum Muenster
-
Nürtingen, Saksa, 72622
- Studienpraxis Urologie Drs. Feyerabend
-
-
-
-
-
Kaohsiung City, Taiwan, 807
- Kaohsiung Medical University Chung Ho Memorial Hospital
-
Taichung, Taiwan, 40705
- Taichung Veterans General Hospital
-
Taichung, Taiwan, 403
- China Medical University Hospital
-
Taichung, Taiwan, 435
- Tungs' Taichung MetroHarbor Hospital
-
Tainan, Taiwan, 710
- Chi Mei Medical Center Yong Kang
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
Taipei, Taiwan, 11217
- Taipei Veterans General Hospital
-
Taoyuan, Taiwan, 33305
- Chang Gung Memorial Hospital
-
-
-
-
-
Adana, Turkki (Türkiye), 01330
- Cukurova University, Faculty of Medicine
-
Ankara, Turkki (Türkiye), 06200
- Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital
-
Ankara, Turkki (Türkiye), 6560
- Ankara Bilkent Sehir Hastanesi
-
Antalya, Turkki (Türkiye), 07070
- Akdeniz University Medical Faculty
-
Edirne, Turkki (Türkiye), 22030
- Trakya University Medical Faculty
-
Istanbul, Turkki (Türkiye), 34722
- Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi
-
Istanbul, Turkki (Türkiye), 34098
- Istanbul University Cerrahpasa Medical Faculty
-
Istanbul, Turkki (Türkiye), 34147
- Bakirkoy Training and Research Hospital
-
Izmir, Turkki (Türkiye), 35575
- IEU Medical Point Hospital
-
Kocaeli, Turkki (Türkiye), 41380
- Kocaeli University Medical Faculty
-
-
-
-
-
Hradec Králove, Tšekki, 500 05
- Fakultni nemocnice Hradec Kralove
-
Liberec, Tšekki, 460 63
- Krajská nemocnice Liberec
-
Olomouc, Tšekki, 77900
- Uromedical Center s.r.o.
-
Pardubice, Tšekki, 53203
- Multiscan s.r.o.
-
Pilsen, Tšekki, 305 99
- Fakultni nemocnice Plzen, Urologicka klinika
-
Prague, Tšekki, 120 00
- Urologicka klinika 1 LF UK a VFN
-
Prague, Tšekki, 140 59
- Thomayerova nemocnice, Onkologicka klinika
-
Uherské Hradiště, Tšekki, 68668
- Uherskohradistska nemocnice a.s.
-
-
-
-
-
Cherkasy, Ukraina, 18009
- CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
-
Dnipo, Ukraina, 49005
- Ce 'Dnipropetrovsk Regional Clinical Hospital N.A. Mechnikov' of Dnipropetrovsk Rc
-
Dnipro, Ukraina, 49102
- Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
-
Dnipro, Ukraina, 49100
- Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council
-
Ivano-Frankivsk, Ukraina, 76008
- Ivano-Frankivsk Regional Clinical Hospital
-
Khakhiv, Ukraina, 61070
- Municipal non-profit enterprise 'Regional Center of Oncology'
-
Kharkiv, Ukraina, 61037
- Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval
-
Kyiv, Ukraina, 03115
- State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center
-
Kyiv, Ukraina, 03022
- State Nonprofit Enterprise National Cancer Institute
-
Lviv, Ukraina, 79010
- University Hospital of SNA Danylo Halytsky LMNU
-
Poltava, Ukraina, 36024
- ME 'Poltava Regional Clinical Hospital n.a. M.V. Sklifosovsky of the Poltava Regional Council'
-
Uzhhorod, Ukraina, 88000
- Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal
-
-
-
-
-
Budapest, Unkari, 1082
- Semmelweis Egyetem, Urológia Klinika
-
Budapest, Unkari, 1122
- Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály
-
Debrecen, Unkari, 4032
- Debreceni Egyetem Klinikai Kozpont
-
Gyula, Unkari, 5700
- Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
-
Nyíregyháza, Unkari, 4400
- Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Josa Andras Oktatokorhaz
-
Pécs, Unkari, 7621
- Uro-Clin Kft.
-
Szeged, Unkari, 6720
- Szegedi Tudomanyegyetem
-
Szeged, Unkari, 6725
- Szegedi Tudomanyegyetem 1
-
Szombathely, Unkari, 9700
- Markusovszky Egyetemi Oktatokorhaz
-
-
-
-
-
Barnaul, Venäjä, 656045
- Altai Regional Oncology Dispensary
-
Ivanovo, Venäjä, 153040
- Ivanovo Regional Oncology Dispensary
-
Kursk, Venäjä, 305524
- GUZ Kursk Regional Oncology Dispensary
-
Moscow, Venäjä, 117997
- Russian Scientific Center of Roentgenoradiology
-
Moscow, Venäjä, 125130
- Moscow City Clinical Hospital # 62
-
Nizhny Novgorod, Venäjä, 603000
- Clinical Diagnostic Centre of Nizhny Novgorod Region
-
Omsk, Venäjä, 644013
- Clinical Oncology Dispensary
-
Pyatigorsk, Venäjä, 357500
- LLC Novaya Clinica
-
Pyatigorsk, Venäjä, 357502
- Pyatigorsk Interdistrict Oncology Dispensary
-
Saint Petersburg, Venäjä, 196603
- Private Medical Institution Euromedservice
-
Saint Petersburg, Venäjä, 197758
- Russian Scientific Center of Radiology and Surgical Technologies
-
Saint Petersburg, Venäjä, 191104
- Leningrad Regional Oncology Dispensary
-
Saransk, Venäjä, 430032
- Republican Oncology Dispensary
-
Sochi, Venäjä, 354057
- Oncologic Dispensary No.2
-
Tambov, Venäjä, 392013
- Tambov Regional Oncology Clinical Dispansary
-
Tomsk, Venäjä, 634050
- Tomsk Cancer Research Institute
-
Tyumen, Venäjä, 625000
- Medical-sanitary unit 'Neftyanik'
-
Vologda, Venäjä, 160012
- Vologda Regional Oncological Dispensary
-
-
-
-
-
Blackburn, Yhdistynyt kuningaskunta, BB2 3HH
- Royal Blackburn Hospital
-
Lancaster, Yhdistynyt kuningaskunta, LA1 4RP
- Royal Lancaster Infirmary
-
London, Yhdistynyt kuningaskunta, WC1E 6DD
- UCL Cancer Institute
-
Torquay, Yhdistynyt kuningaskunta, TQ2 7AA
- Torbay Hospital-Devon
-
Truro, Yhdistynyt kuningaskunta, TR1 3LJ
- Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
-
Wolverhampton, Yhdistynyt kuningaskunta, WV10 0QP
- New Cross Hospital
-
-
-
-
Alabama
-
Homewood, Alabama, Yhdysvallat, 35209
- Urology Centers Of Alabama
-
-
Arizona
-
Phoenix, Arizona, Yhdysvallat, 85054
- Mayo Clinic Arizona
-
Tucson, Arizona, Yhdysvallat, 85741
- Urological Associates of Southern Arizona, P.C.
-
-
Arkansas
-
Little Rock, Arkansas, Yhdysvallat, 72211
- Arkansas Urology
-
-
California
-
Riverside, California, Yhdysvallat, 92505
- Kaiser Permanente
-
San Bernardino, California, Yhdysvallat, 92404
- San Bernardino Urological Associates
-
San Francisco, California, Yhdysvallat, 94158
- University of California San Francisco
-
Santa Barbara, California, Yhdysvallat, 93105
- Sansum Clinic Pharm
-
-
Colorado
-
Denver, Colorado, Yhdysvallat, 80211
- The Urology Center of Colorado
-
Lakewood, Colorado, Yhdysvallat, 80228
- Colorado Clinical Research
-
-
Connecticut
-
West Haven, Connecticut, Yhdysvallat, 06516
- VA Connecticut Healthcare
-
-
Florida
-
Bay Pines, Florida, Yhdysvallat, 33744
- Bay Pines VA Healthcare System
-
Daytona Beach, Florida, Yhdysvallat, 32114
- Advanced Urology Institute
-
Jacksonville, Florida, Yhdysvallat, 32209
- University of Florida Health Jacksonville
-
Jacksonville, Florida, Yhdysvallat, 32224
- Mayo Clinic - Division Of Hematology/oncology
-
-
Illinois
-
Hines, Illinois, Yhdysvallat, 60141
- Veterans Affairs Medical Ctr
-
-
Indiana
-
Fort Wayne, Indiana, Yhdysvallat, 46825
- Fort Wayne Medical Oncology and Hematology
-
Jeffersonville, Indiana, Yhdysvallat, 47130
- First Urology
-
-
Kansas
-
Kansas City, Kansas, Yhdysvallat, 66160
- University of Kansas Medical Center
-
-
Kentucky
-
Louisville, Kentucky, Yhdysvallat, 40202
- Norton Healthcare
-
-
Louisiana
-
New Orleans, Louisiana, Yhdysvallat, 70121
- Ochsner Clinic Foundation
-
-
Maryland
-
Bethesda, Maryland, Yhdysvallat, 20817
- Rcca Md, Llc
-
Towson, Maryland, Yhdysvallat, 21204
- Chesapeake Urology Research Associates
-
-
Massachusetts
-
Boston, Massachusetts, Yhdysvallat, 02114
- Massachusetts General
-
-
Michigan
-
Troy, Michigan, Yhdysvallat, 48084
- Michigan Institute of Urology
-
-
Missouri
-
Kansas City, Missouri, Yhdysvallat, 64128
- Kansas City Veterans Affairs Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Yhdysvallat, 68130
- Nebraska Cancer Specialists
-
Omaha, Nebraska, Yhdysvallat, 68114
- Adult Pediatric Urology & Urogynecology, P.C
-
-
Nevada
-
Las Vegas, Nevada, Yhdysvallat, 89169
- Comprehensive Cancer Centers of Nevada
-
-
New Jersey
-
Mount Laurel, New Jersey, Yhdysvallat, 08054
- Delaware Valley Urology, LLC
-
-
New York
-
Albany, New York, Yhdysvallat, 12208
- New York Oncology Hematology
-
New York, New York, Yhdysvallat, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Yhdysvallat, 10029
- Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg
-
Syracuse, New York, Yhdysvallat, 13210
- Upstate Cancer Center
-
-
Ohio
-
Middleburg Heights, Ohio, Yhdysvallat, 44130
- Helios Clinical Research, LLC
-
-
Oregon
-
Springfield, Oregon, Yhdysvallat, 97477
- Oregon Urology Institute
-
-
Pennsylvania
-
Bala-Cynwyd, Pennsylvania, Yhdysvallat, 19004
- MidLantic Urology
-
Lancaster, Pennsylvania, Yhdysvallat, 17604
- Lancaster Urology
-
Pittsburgh, Pennsylvania, Yhdysvallat, 15240
- VA Pittsburgh
-
-
South Carolina
-
Myrtle Beach, South Carolina, Yhdysvallat, 29572
- Carolina Urologic Research Center
-
-
Tennessee
-
Nashville, Tennessee, Yhdysvallat, 37209
- Urology Associates
-
-
Texas
-
Houston, Texas, Yhdysvallat, 77030
- University of Texas MD Anderson Cancer Center
-
Houston, Texas, Yhdysvallat, 77027
- Houston Metro Urology
-
-
Utah
-
Salt Lake City, Utah, Yhdysvallat, 84106
- Utah Cancer Specialists
-
-
Virginia
-
Salem, Virginia, Yhdysvallat, 80113
- Salem VA Medical Center
-
Virginia Beach, Virginia, Yhdysvallat, 23462
- Urology of Virginia, PLCC
-
-
Washington
-
Tacoma, Washington, Yhdysvallat, 98405
- NorthWest Medical Specialties, PLLC
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
-
HRR gene alteration (as identified by the sponsor's required assays) as follows:
- Cohort 1: positive for HRR gene alteration
- Cohort 2: not positive for DRD (that is, HRR gene alteration)
- Cohort 3: eligible by HRR status
-
Metastatic disease documented by positive bone scan or metastatic lesions on computed tomography (CT) or magnetic resonance imaging (MRI)
-
Metastatic prostate cancer in the setting of castrate levels of testosterone less than or equal to (<=) 50 nanogram per deciliter (ng/dL) on a gonadotropin releasing hormone analog (GnRHa) or bilateral orchiectomy
-
Able to continue GnRHa during the study if not surgically castrate
-
Score of <= 3 on the brief pain inventory-short form (BPI-SF) question number 3 (worst pain in last 24 hours)
Exclusion Criteria:
- Prior treatment with a poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor
- Systemic therapy (that is, novel second-generation AR-targeted therapy such as enzalutamide, apalutamide, or darolutamide; taxane-based chemotherapy, or more than 4 months of abiraterone acetate plus prednisone [AAP] prior to randomization) in the metastatic castration-resistant prostate cancer (mCRPC) setting; or AAP outside of the mCRPC setting
- Symptomatic brain metastases
- History or current diagnosis of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML)
- Other prior malignancy (exceptions: adequately treated basal cell or squamous cell skin cancer, superficial bladder cancer, or any other cancer in situ currently in complete remission) <= 2 years prior to randomization, or malignancy that currently requires active systemic therapy
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Nelinkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Cohort 1: Participants with mCRPC and HRR Gene Alteration
Participants with L1 metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alteration will receive combination of niraparib 200 milligrams (mg) or matching placebo and abiraterone acetate (AA) 1000 mg plus prednisone 10 mg. In the open label extension (OLE) phase participants earlier receiving the combination of niraparib and AAP may continue to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg and those receiving placebo and AAP may cross over depending on the outcome of study to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg. |
Participants will receive niraparib 200 mg capsules or tablets once daily.
Muut nimet:
Participants will receive AA 1000 mg tablets once daily. Participants will receive prednisone 10 mg tablets daily. Participants will receive matching placebo once daily. |
|
Kokeellinen: Cohort 2: Participants with mCRPC and No HRR Gene Alteration
Participants with L1 mCRPC and no HRR Gene alteration will receive combination of niraparib 200 mg or matching placebo and AA 1000 mg plus prednisone 10 mg. In the OLE phase participants earlier receiving the combination of niraparib and AAP may continue to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg and those receiving placebo and AAP may cross over depending on the outcome of study to receive open-label combination of niraparib 200 mg and AA 1000 mg plus prednisone 10 mg. |
Participants will receive niraparib 200 mg capsules or tablets once daily.
Muut nimet:
Participants will receive AA 1000 mg tablets once daily. Participants will receive prednisone 10 mg tablets daily. Participants will receive matching placebo once daily. |
|
Kokeellinen: Cohort 3 (Open-label): Participants with mCRPC
Participants with mCRPC will receive a new formulation of niraparib 200 mg and AA 1000 mg tablets plus prednisone 10 mg. |
Participants will receive prednisone 10 mg tablets daily. Participants will receive a new formulation of niraparib 200 mg and AA 1000 mg tablets once daily. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Cohort 1: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR)
Aikaikkuna: Up to 32 months
|
As per BICR, rPFS is time interval from the date of randomization to radiographic progression or death, whichever occurred first. Radiographic progression was determined by: (1) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI) as per response evaluation criteria in solid tumors (RECIST) 1.1; (2) Progression of bone lesions observed by bone scan based on prostate cancer working group 3 (PCWG3) criteria. PCWG3 criteria: bone progression was confirmed by subsequent scan greater than or equal to (>=) 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. Confirmatory scan >=2 new lesions indicate progression; scan does not show >=2 new lesions means no progression. If Week 8 scan less than (<) 2 new bone lesions compared to baseline, the initial scan >=2 new lesions compared to Week 8 scan indicates progression if confirmed by subsequent scan >=6 weeks later. |
Up to 32 months
|
|
Cohort 1 Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR)
Aikaikkuna: Up to 32 months
|
As per BICR, rPFS is time interval from the date of randomization to radiographic progression or death, whichever occurred first. Radiographic progression was determined by: (1) progression of soft tissue lesions measured by CT or MRI as per RECIST 1.1; (2) Progression of bone lesions observed by bone scan based on PCWG3 criteria. PCWG3 criteria: bone progression was confirmed by subsequent scan >=6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. Confirmatory scan >=2 new lesions indicate progression; scan does not show >=2 new lesions means no progression. If Week 8 scan <2 new bone lesions compared to baseline, the initial scan >=2 new lesions compared to Week 8 scan indicates progression if confirmed by subsequent scan >=6 weeks later. |
Up to 32 months
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Aikaikkuna |
|---|---|
|
Kohortti 1: kokonaiseloonjääminen (OS)
Aikaikkuna: Jopa 97 kuukautta
|
Jopa 97 kuukautta
|
|
Kohortti 1: Aika oireiden etenemiseen
Aikaikkuna: Jopa 97 kuukautta
|
Jopa 97 kuukautta
|
|
Kohortti 1: Aika sytotoksisen kemoterapian aloittamiseen
Aikaikkuna: Jopa 97 kuukautta
|
Jopa 97 kuukautta
|
|
Niraparibin havaitut plasmapitoisuudet
Aikaikkuna: Jopa 97 kuukautta
|
Jopa 97 kuukautta
|
|
Abirateronin havaitut plasmapitoisuudet
Aikaikkuna: Jopa 97 kuukautta
|
Jopa 97 kuukautta
|
|
Niiden osallistujien määrä, joilla on hoitoon liittyviä haittavaikutuksia (TEAE)
Aikaikkuna: Jopa 96 kuukautta
|
Jopa 96 kuukautta
|
|
Hoitoon liittyvien haittatapahtumien osallistujien määrä vakavuuden mukaan
Aikaikkuna: Jopa 96 kuukautta
|
Jopa 96 kuukautta
|
|
Niiden osallistujien määrä, joilla on poikkeavuuksia laboratorioarvoissa
Aikaikkuna: Jopa 96 kuukautta
|
Jopa 96 kuukautta
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Opintojohtaja: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Roubaud G, Attard G, Boegemann M, Olmos D, Trevisan M, Antoni L, Pascoe K, Capone C, Van Sanden S, Hashim M, Palmer S, Chi K. Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer. Eur J Cancer. 2024 Sep;209:114183. doi: 10.1016/j.ejca.2024.114183. Epub 2024 Jun 17.
- Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23.
- Rathkopf DE, Roubaud G, Chi KN, Efstathiou E, Attard G, Olmos D, Small EJ, Saad M, Castro E, Kim W, Wu D, Bertzos K, Dibaj S, Zhang J, Francis P, Smith MR. Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial. Eur Urol. 2025 Oct;88(4):359-369. doi: 10.1016/j.eururo.2024.09.003. Epub 2024 Sep 23.
- De Santis M, Breijo SM, Robinson P, Capone C, Pascoe K, Van Sanden S, Hashim M, Trevisan M, Daly C, Reitsma F, van Beekhuizen S, Ruan H, Heeg B, Verzoni E. Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer. Adv Ther. 2024 Aug;41(8):3039-3058. doi: 10.1007/s12325-024-02918-6. Epub 2024 Jul 3.
- Ye D, Saad M, Lee JY, Jung W, Pang ST, Li L, Gurney H, Attard G, Chi KN, Mundle S, Zhuo J, Singh A, Lin Y, Sandhu S. Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study. Int J Urol. 2026 Apr;33(4):e70455. doi: 10.1111/iju.70455.
- Russu A, Hazra A, Tian H, Haddish-Berhane N, Perez Ruixo JJ, Boulton M. Population Pharmacokinetics of Niraparib/Abiraterone Acetate Administered as Single-Agent Combination and Dual-Acting Tablets Plus Prednisone for Metastatic Castration-Resistant Prostate Cancer. Adv Ther. 2025 Apr;42(4):1860-1880. doi: 10.1007/s12325-025-03104-y. Epub 2025 Feb 28.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
- Urogenitaaliset sairaudet
- Sukuelinten sairaudet
- Sukuelinten kasvaimet, mies
- Urogenitaaliset kasvaimet
- Neoplasmat sivustoittain
- Neoplasmat
- Sukuelinten sairaudet, mies
- Eturauhasen sairaudet
- Miesten urogenitaaliset sairaudet
- Eturauhasen kasvaimet
- Kastraatioresistentit eturauhasen kasvaimet
- Polisykliset yhdisteet
- Raskaat
- Raskaat
- Steroidit
- Sulatettu rengasyhdisteet
- Raskaat
- Androstenes
- Androstanes
- Abirateroniasetaatti
- Prednisoni
- niraparib
Muut tutkimustunnusnumerot
- CR108534
- 2017 (Yhdysvaltain NIH-apuraha/sopimus)
- 2017-003364-12 (EudraCT-numero)
- 64091742PCR3001 (Muu tunniste: Janssen Research & Development, LLC)
- 2023-503254-12-00 (Rekisterin tunniste: EUCT number)
- 2023 (Yhdysvaltain NIH-apuraha/sopimus)
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .